Lung nodules
-
If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or follow local emergency care protocols or seek emergent medical advice if in a remote region.
- No emergency indicators identified; routine prioritisation applies
-
Request for advice
Available to GPs who use GPSR and available at your local Health Service
- Lung nodule(s) identified where:
- The GP requires further management advice
- Guidance is not available on HealthPathways
- The case does not clearly fit into any other referral categories
- Guidance is required in specific patient groups, such as the follow up of small pulmonary nodules (<6mm) in patients with a personal history of cancer.
Other Useful Information
- Refer to HealthPathways or local guidelines.
- National Lung Cancer Screening Program
- National Lung Cancer Screening Program | Australian Government Department of Health, Disability and Ageing
- National Lung Cancer Screening Program – Guidelines | Australian Government Department of Health, Disability and Ageing
- National Lung Cancer Screening Program – Nodule management protocol | Australian Government Department of Health, Disability and Ageing
- Fleischner Society Guidelines 2017 | Timing for Follow-Up CT scans for incidental Lung Nodules1
Type Risk2 <6mm 6-8mm (≥6 for subsolid) Solid Single Low None 6-12 months then consider at 18-24 months High 12 months (optional) 6-12 months then at 18-24 months Multiple Low None 3-6 months then consider at 18-24 months High 12 months (Optional) 3-6 months then at 18-24 months Non-solid No routine follow-up 6-12 months then 2-yearly for 5 yrs Part-solid No routine follow-up 3-6 months then yearly for 5 yrs Multiple 3-6 months then annual for 5 years 3-6 months then based on most suspicious - Nodules that do not require referral include:
- Nodules with diffuse, central, laminated or popcorn patterns of calcification or macroscopic fat
- Juxtapleural (perifissural) nodules with characteristic triangular morphology < 10 mm diameter
- Solid nodules stable for at least 2 years
- Non-solid, part solid and atypical pulmonary cysts stable for at least 5 years
1Not intended for patients <35 years, lung cancer screening, history of cancer or immunocompromised
2High-risk factors include older age, heavy smoking, irregular or spiculated margins, and upper lobe location.- Review of previous imaging is very important to determine if nodules are new, enlarging, stable or decreased.
- Follow up imaging of nodules should be performed at the same radiology service and on the same equipment, if possible.
- Lung nodule(s) identified where:
| Category 1 (appointment within 30 calendar days) |
Lung nodules are traditionally defined as ≤30 mm in diameter. This section is relevant to both screening detected and incidental (scan performed for a different reason) lung nodules.Any one of the following:
(1) Dimensions are average of long and short axes, rounded to the nearest millimetre. Where only the largest diameter is provided in the imaging Report, this measurement can be considered |
||||||||||||||||||||||||
| Category 2 (appointment within 90 calendar days) |
Any one of the following:
(1) Dimensions are average of long and short axes, rounded to the nearest millimeter. Where only the largest diameter is provided in the imaging Report, this measurement can be considered as a surrogate for the average. |
||||||||||||||||||||||||
| Category 3 (appointment within 365 calendar days) |
|
||||||||||||||||||||||||
Please insert the below information and minimum referral criteria into referral
1. Reason for request Indicate on the referral
- To establish a diagnosis
- For treatment or intervention
- For advice and management
- For specialist to take over management
- Reassurance for GP/second opinion
- For a specified test/investigation the GP can't order, or the patient can't afford or access
- Reassurance for the patient/family
- For other reason (e.g. rapidly accelerating disease progression)
- Clinical judgement indicates a referral for specialist review is necessary
2. Essential referral information Referral will be returned without this
- Chest imaging and details of radiology provider
- Details and pathology results (if available) of previous malignancies
- NLCSP screening report, if applicable
- Patient characteristics which influence risk of malignancy:
- Personal history of cancers
- Patient history, symptoms, and indication for CT (if CT performed for respiratory (infective) symptoms, consider short interval repeat CT depending on radiological likelihood of malignancy (e.g., 8–12 weeks)
- Detailed smoking history including tobacco, marijuana, electronic cigarettes, and illicit drugs
- Family history of lung cancer
- Ethnicity
- Occupational exposures
- Known underlying lung disease, for example, COPD, Interstitial lung disease
- Medications, for example, anticoagulation, immunosuppressive drugs
3. Additional referral information Useful for processing the referral
- Historical imaging (if available)
- FBC, ELFT and any other relevant pathology results
4. Request
-
Patient's Demographic Details
- Full name (including aliases)
- Date of birth
- Residential and postal address
- Telephone contact number/s – home, mobile and alternative
- Medicare number (where eligible)
- Name of the parent or caregiver (if appropriate)
- Preferred language and interpreter requirements
- Identifies as Aboriginal and/or Torres Strait Islander
Referring Practitioner Details
- Full name
- Full address
- Contact details – telephone, fax, email
- Provider number
- Date of referral
- Signature
Relevant clinical information about the condition
- Presenting symptoms (evolution and duration)
- Physical findings
- Details of previous treatment (including systemic and topical medications prescribed) including the course and outcome of the treatment
- Body mass index (BMI)
- Details of any associated medical conditions which may affect the condition or its treatment (e.g. diabetes), noting these must be stable and controlled prior to referral
- Current medications and dosages
- Drug allergies
- Alcohol, tobacco and other drugs use
Reason for request
- To establish a diagnosis
- For treatment or intervention
- For advice and management
- For specialist to take over management
- Reassurance for GP/second opinion
- For a specified test/investigation the GP can't order, or the patient can't afford or access
- Reassurance for the patient/family
- For other reason (e.g. rapidly accelerating disease progression)
- Clinical judgement indicates a referral for specialist review is necessary
Clinical modifiers
- Impact on employment
- Impact on education
- Impact on home
- Impact on activities of daily living
- Impact on ability to care for others
- Impact on personal frailty or safety
- Identifies as Aboriginal and/or Torres Strait Islander
Other relevant information
- Willingness to have surgery (where surgery is a likely intervention)
- Choice to be treated as a public or private patient
- Compensable status (e.g. DVA, Work Cover, Motor Vehicle Insurance, etc.)
-
If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or follow local emergency care protocols or seek emergent medical advice if in a remote region.
- Please note that where appropriate and where available, the referral may be streamed to an associated public allied health and/or nursing service. Access to some specific services may include initial assessment and management by associated public allied health and/or nursing, which may either facilitate or negate the need to see the public medical specialist.
- A change in patient circumstance (such as condition deteriorating or becoming pregnant) may affect the urgency categorisation and should be communicated as soon as possible.
- Please indicate in the referral if the patient is unable to access mandatory tests or investigations as they incur a cost or are unavailable locally.
Last updated: 3 July 2025
© State of Queensland (Queensland Health) 2023
Except as permitted under the Copyright Act 1968, no part of this work may be reproduced, communicated or adapted without permission from Queensland Health. To request permission email ip_officer@health.qld.gov.au1.